Inhibition of N- and L-type calcium channels by muscarinic receptor activation in rat sympathetic neurons

Neuron. 1992 May;8(5):907-14. doi: 10.1016/0896-6273(92)90205-r.

Abstract

Modulation of N- and L-type Ca2+ channels by oxotremorine-M (oxo-M) acting on muscarinic receptors and norepinephrine (NE) acting on alpha-adrenergic receptors was studied in superior cervical ganglion neurons. Oxo-M depresses dihydropyridine-augmented tail currents in whole-cell recordings, whereas NE does not. This modulation of L-type Ca2+ channels by oxo-M is abolished by adding 20 mM BAPTA to the pipette solution. Oxo-M, acting via a diffusible messenger, reduces the probability of opening of single N- and L-type channels recorded in cell-attached patches. We conclude that a diffusible messenger signaling pathway activated by oxo-M inhibits both N- and L-type Ca2+ channels, whereas a membrane-delimited pathway activated by oxo-M and NE inhibits only N-type Ca2+ channels.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Calcium Channels / drug effects
  • Calcium Channels / physiology*
  • Dihydropyridines / pharmacology
  • Electric Conductivity
  • Ganglia, Sympathetic / physiology*
  • Male
  • Neurons / physiology*
  • Norepinephrine / pharmacology
  • Oxotremorine / analogs & derivatives
  • Oxotremorine / pharmacology
  • Rats
  • Rats, Inbred Strains
  • Receptors, Adrenergic, alpha / drug effects
  • Receptors, Adrenergic, alpha / physiology
  • Receptors, Muscarinic / drug effects
  • Receptors, Muscarinic / physiology*

Substances

  • Calcium Channels
  • Dihydropyridines
  • Receptors, Adrenergic, alpha
  • Receptors, Muscarinic
  • Oxotremorine
  • oxotremorine M
  • 1,4-dihydropyridine
  • Norepinephrine